Manufacturers Life Insurance Company, The Aquestive Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 28,041 shares of AQST stock, worth $98,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,041
Previous 29,371
4.53%
Holding current value
$98,704
Previous $76,000
82.89%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AQST
# of Institutions
122Shares Held
46.8MCall Options Held
517KPut Options Held
207K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$34.5 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$19.6 Million2.87% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$19.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$15 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.77MShares$9.74 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $188M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...